Page last updated: 2024-08-24

25-hydroxycholesterol and Lung Neoplasms

25-hydroxycholesterol has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, G; Jia, W; Li, J; Liu, J; Liu, L; Miao, P; Song, S; Sun, X; Yan, H; Yang, H; Zhao, L; Zhao, X; Zhou, X1
Chen, L; Lin, Y; Lv, Y; Wang, Y; Xian, G; Zhang, L1

Other Studies

2 other study(ies) available for 25-hydroxycholesterol and Lung Neoplasms

ArticleYear
Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells.
    Oncotarget, 2016, Aug-09, Volume: 7, Issue:32

    Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Gefitinib; Humans; Hydroxycholesterols; Lung Neoplasms; Membrane Proteins; Mice; Mice, Nude; Microtubule-Associated Proteins; Protein Kinase Inhibitors; Pyridines; Quinazolines; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Thiazoles; Triterpenes; Xenograft Model Antitumor Assays

2016
25-Hydroxycholesterol promotes migration and invasion of lung adenocarcinoma cells.
    Biochemical and biophysical research communications, 2017, 03-18, Volume: 484, Issue:4

    Topics: A549 Cells; Adenocarcinoma; Cell Movement; Humans; Hydroxycholesterols; Interleukin-1beta; Liver X Receptors; Lung Neoplasms; Neoplasm Invasiveness; Peptide Fragments

2017